Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Advisor, Clinical Science to provide scientific and clinical leadership for the design, execution, and interpretation of early-stage Phase 1/2 clinical trials for Orexin-targeted programs in neurodegeneration and neuropsychiatric indications. The role is a key scientific and cross-functional position, partnering with Clinical Development, Clinical Operations, Translational Science, Regulatory Affairs, Biostatistics, and Safety/Pharmacovigilance, with significant responsibility for study-level scientific strategy and execution. Reporting to the Executive Director, Clinical Development, the Senior Advisor will lead authorship of key clinical and regulatory documents, drive ongoing clinical data review and interpretation, contribute to dose-escalation and development-strategy decisions, and provide scientific leadership across internal governance and cross-functional forums. The position is remote and based in the United States, with occasional travel. Centessa is a clinical-stage company developing orexin receptor 2 (OX2R) agonists for narcolepsy and potentially other sleep-wake disorders. Its lead investigational candidate, cleminorexton (formerly ORX750), is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Its broader OX2R agonist portfolio includes clinical- and preclinical-stage assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior